|
Babkin A.P.
New diagnostic capabilities of the 6-minute walk test in COPD patients
|
5-8 |
|
Bala A.Ya.
Various manifestation of kidney damage with in COVID-19
|
9-13 |
|
Batishcheva G.A., Vlasenkova A.A., Goncharova N.Yu., Cherenkova O.V.
Clinical guidelines and real antimicrobial pharmacotherapy of patients with rhinosinusitis
|
14-18 |
|
Budnevsky A.V., Kravchenko A.Ya., Tokmachev R.E. Chernik T.A.
Impact of physical rehabilitation on the course of chronic heart failure
|
19-22 |
|
Vasilyeva L.V., Suslova E.Yu., Gosteva E.V.
Pathogenic factors of Helicobacter pylori in patients with coronary heart disease in combination with peptic ulcer
|
23-27 |
|
Volynkina A.P., Elizarova I.O., Karpenko Yu.Yu.
Assessment of information awareness in the prevention of type 2 diabetes among medical university students
|
28-31 |
|
Gosteva E.V., Vasilyeva L.V., Suslova E.Yu., Inshakova K.Yu.
Association of cardiovascular risk factors and vitamin D status in patients with metabolic syndrome
|
32-37 |
|
Drobysheva E.S., Ovsyannikov E.S., Drobysheva V.R.
Prognostic significance of the cytokine profile in patients with autoimmune thyroiditis
|
38-40 |
|
Dronova Y.M., Belesikova V.V.
The validity of prescribing drug prevention of gastroduodenal bleeding in patients with chronic ischemic heart disease
|
41-45 |
|
Elizarova I.O., Chernykh T.M., Zoloyedov V.I.
Some clinical features of the combination of diabetes mellitus and COVID-19
|
46-49 |
|
Yesina E.Yu., Zuikova A.A., Kotova Yu.A.
The relationship of environmental risk factors and cardiovascular diseases in hypertensive patients living in rural areas
|
50-53 |
|
Efremova L.S., Vasilyeva L.V.
Relationship of aldosterone and tissue inhibitor of matrix metalloproteinase-1 in the pathogenesis of chronic heart failure with a moderately reduced ejection fraction in patients with diabetes mellitus
|
54-57 |
|
Zuikova A.A., Shevtsova V.I., Kurguzova A.S., Dobrynina I.S.
Assessment of nutritional status in patients with diabetes mellitus in the presence of macrovascular complications and without them
|
58-61 |
|
Korolkova O.M., Chernykh T.M.
Case of treatment of a patient with idiopathic pulmonary hypertension and COVID-19
|
62-67 |
|
Kravchenko A.Ya., Chernik T.A., Tokmachev R.E.
Soluble suppression of tumorigenicity 2 (sST2) in chronic heart failure
|
68-70 |
|
Lagutina S.N., Zuikova A.A., Dobrynina I.S., Kotova Yu.A.
New ways for diagnostics of non-specific ulcerative colitis
|
71-74 |
|
Lagutina S.N., Zuikova A.A., Dobrynina I.S., Kotova Yu.A.
Assessment of the biodiversity of the intestinal microbiota as a new diagnostic sign of metabolic disorders
|
75-78 |
|
Mikhaylenko E.V., Abdullaev Sh.P., Sychev D.A., Tchubarev V.N., Skripka A.I.
Pharmacoeconomic evaluation of genotype-guided dabigatran etexilate dosing in patients with atrial fibrillation and chronic kidney disease
|
79-83 |
|
Nalotov S.V., Nalotova O.S., Korovka I.A., Nalotova E.N., Alesinsky M.M., Tverdochleb T.A.
Quality of life of patients with arterial hypertension including in standard antihypertensive pharmacotherapy quercetin/dihydroquercetin
|
84-88 |
|
Nedomolkina S.A., Zuikova A.A., Velikiy A.V.
Anemic syndrome in patients with diabetes mellitus
|
89-93 |
|
Nekrasova N.V., Elizarova I.O., Gridin A.A.
Experience of using Laennec in the treatment of bridge-like complications
|
94-98 |
|
Ovsyannikov E.S., Feygelman S.N., Alexeeva N.G.
On the issue of cough treatment in COVID-19 patients
|
99-102 |
|
Pertsev A.V., Rezova N.V., Shkatova Ya.S.
Influence of antihypertensive therapy on affected target organs in hypertension disease
|
103-105 |
|
Rezova N.V., Pertsev A.V., Shkatova Ya.S.
The special role of melatonin in the development of hypertension
|
106-108 |
|
Simion A.Yu., Ovsyannikov E.S., Drobysheva E.S.
Influence of anemic syndrome in patients with coronary heart disease on the main parameters of quality of life
|
109-112 |
|
Chernykh T.M., Babenko N.I.
Prevalence of main risk factors for cardiovascular diseases in a non-organized population: focus on hypercholesterolemia
|
113-117 |
|
Chernykh T.M., Zoloedov V.I., Korolkova O.M., Babenko N.I., Popovskaya D.P.
Academician N.I. Leporsky – coryphaeus of the Russian therapeutic school
|
118-122 |
|
Shevtsova V.I., Kurguzova A.S., Dobrynina I.S.
The effectiveness of dispensary observation of patients with hypertension
|
123-126 |
Русский
